STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATEX
  4. [Form 4] Anterix Inc. Insider Trading Activity

Anterix (ATEX) awards RSUs and stock options to chief legal officer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Anterix Inc. reported that Chief Legal Officer & Corporate Secretary Gena L. Ashe received equity awards as compensation. She was granted 3,694 restricted stock units, increasing her direct common stock holdings to 16,032 shares. She also received options for 17,453 shares at an exercise price of $60.90 per share, expiring on May 20, 2036. Both the RSUs and options vest over three years, with one-third vesting on May 20, 2027 and the remainder vesting in equal quarterly installments through May 20, 2029.

Positive

  • None.

Negative

  • None.
Insider Ashe Gena L
Role Chief Legal Officer & Corp Sec
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 17,453 $0.00 --
Grant/Award Common Stock 3,694 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 17,453 shares (Direct, null); Common Stock — 16,032 shares (Direct, null)
Footnotes (1)
  1. Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029. The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
RSUs granted 3,694 RSUs Restricted stock units granted to Gena L. Ashe on May 20, 2026
Options granted 17,453 options Stock Option (Right to Buy) granted on May 20, 2026
Option exercise price $60.90 per share Conversion or exercise price for newly granted options
Option expiration May 20, 2036 Expiration date of stock options
Shares held after grant 16,032 shares Total Anterix common shares directly held by Ashe after RSU grant
restricted stock units ("RSUs") financial
"Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with 17,453.0000 shares and a $60.9000 exercise price"
vest financial
"The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price of 60.9000 for the stock option award"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
contingent right financial
"Each RSU represents a contingent right to receive one share of Issuer's Common Stock"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ashe Gena L
(Last)(First)(Middle)
3 GARRET MOUNTAIN PLAZA
SUITE 401
(Street)
WOODLAND PARK NEW JERSEY 07424
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer & Corp Sec
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A3,694(1)A$016,032D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$60.905/20/2026A17,453 (2)05/20/2036Common Stock17,453$017,453D
Explanation of Responses:
1. Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
2. The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
Remarks:
/s/ Gena L. Ashe05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR